The U.S. Court of Appeals for the Federal Circuit in a Dec. 2 order, denied a petition from plaintiff-appellants ARP Materials and Harrison Steel Castings Co. for a panel rehearing and rehearing en banc in a case over whether a protest is needed to retroactively apply Section 301 duty exclusions (ARP Materials v. United States, Fed. Cir. #21-2176).
Sens. Bob Menendez, D-N.J., and Bill Cassidy, R-La., introduced a bill that would refund tariffs on imports that were hit with 25% tariffs during the Airbus-Boeing dispute, and also would prevent tariffs from being applied to goods on the water in the future.
CBP issued the following releases on commercial trade and related matters:
The following lawsuits were recently filed at the Court of International Trade:
The Customs Rulings Online Search System (CROSS) was updated Nov. 29 with the following headquarters rulings (ruling revocations and modifications will be detailed elsewhere in a separate article as they are announced in the Customs Bulletin):
Sen. Mark Warner, D-Va., one of the primary movers behind the Chips Act, told an audience that more domains need policymakers' attention so that they don't wake up to find that China has become dominant in an important emerging technology. He noted that before becoming a politician, he "was in the telecommunication space," and said that realizing that China is dominating 5G with two heavily subsidized champion companies was the "final wake-up call" that engagement and deeper trade with China is not the right way to go.
International Trade Today is providing readers with the top stories from last week in case they were missed. All articles can be found by searching on the titles or by clicking on the hyperlinked reference number.
Sen. Mark Warner, D-Va., one of the primary movers behind the Chips Act, told an audience that more domains need policymakers' attention so that they don't wake up to find that China has become dominant in an important emerging technology. He noted that before becoming a politician, he "was in the telecommunication space," and said that realizing that China is dominating 5G with two heavily subsidized champion companies was the "final wake-up call" that engagement and deeper trade with China is not the right way to go.
The early submissions to the Office of the U.S. Trade Representative on whether the 7.5% and 25% tariffs on Chinese goods should continue were heavily against continuing the action. More than 90% of the 27 submissions either said end all the tariffs or urged dropping the ones that affect businesses or workers.
Exclusions from Section 301 China tariffs for 81 medical care products related to COVID-19 will be extended until the end of February 2023, the Office of the U.S. Trade Representative said in a pre-publication notice released Nov. 23. The exclusions had been set to expire Nov. 30.